HUT74167A - A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol - Google Patents

A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol Download PDF

Info

Publication number
HUT74167A
HUT74167A HU9600376A HU9600376A HUT74167A HU T74167 A HUT74167 A HU T74167A HU 9600376 A HU9600376 A HU 9600376A HU 9600376 A HU9600376 A HU 9600376A HU T74167 A HUT74167 A HU T74167A
Authority
HU
Hungary
Prior art keywords
starch
progesterone
pharmaceutical composition
composition according
estradiol
Prior art date
Application number
HU9600376A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9600376D0 (en
Inventor
Karen Susanne Gram
Annelise Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of HU9600376D0 publication Critical patent/HU9600376D0/hu
Publication of HUT74167A publication Critical patent/HUT74167A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
HU9600376A 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol HUT74167A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (da) 1993-08-20 1993-08-20 Farmaceutisk formulering indeholdende et hormon

Publications (2)

Publication Number Publication Date
HU9600376D0 HU9600376D0 (en) 1996-04-29
HUT74167A true HUT74167A (en) 1996-11-28

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9600376A HUT74167A (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol

Country Status (17)

Country Link
EP (1) EP0789560A1 (ko)
JP (1) JPH09501682A (ko)
KR (1) KR960703570A (ko)
CN (1) CN1132478A (ko)
AU (1) AU7530594A (ko)
BR (1) BR9407306A (ko)
CA (1) CA2169840A1 (ko)
CZ (1) CZ42596A3 (ko)
DK (1) DK95093D0 (ko)
FI (1) FI960749A (ko)
HU (1) HUT74167A (ko)
LT (1) LT4043B (ko)
NO (1) NO960653D0 (ko)
NZ (1) NZ271617A (ko)
PL (1) PL313113A1 (ko)
SK (1) SK19396A3 (ko)
WO (1) WO1995005807A1 (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
FR2775599B1 (fr) * 1998-03-09 2001-08-17 Besins Iscovesco Lab Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
JP4354667B2 (ja) * 1999-08-31 2009-10-28 バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト 避妊薬としての使用へのエチニルエストラジオールとドロスピレノンの医薬用組合せ
US6544553B1 (en) 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768A (fi) * 2000-12-18 2002-06-19 Licentia Oy Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
AU2002242339A1 (en) * 2002-03-14 2003-09-29 Watson Pharmaceuticals, Inc. Progesterone oral drug delivery system
AU2004234057A1 (en) * 2003-04-29 2004-11-11 Akzo Nobel N.V. Antisolvent solidification process
AU2006287925B2 (en) 2005-04-28 2012-03-01 Wyeth Compositions containing micronized tanaproget
EP2055306A1 (de) * 2007-11-05 2009-05-06 Bayer Schering Pharma AG Verwendung eines Gestagens in Kombination mit einem Estrogen und einem oder mehreren pharmazeutisch annehmbaren hilfsstoffen/Trägern zur laktosefreien oralen Kontrazeption
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
BR112017027688A2 (pt) 2015-06-22 2018-09-04 Lipocine Inc Composições orais que contêm éster de 17- hidroxiprogesterona e métodos relacionados
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (fr) 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
WO1990008537A1 (en) * 1989-02-06 1990-08-09 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Also Published As

Publication number Publication date
CA2169840A1 (en) 1995-03-02
DK95093D0 (da) 1993-08-20
NO960653L (no) 1996-02-19
AU7530594A (en) 1995-03-21
KR960703570A (ko) 1996-08-31
LT4043B (en) 1996-09-25
PL313113A1 (en) 1996-06-10
EP0789560A1 (en) 1997-08-20
SK19396A3 (en) 1997-03-05
HU9600376D0 (en) 1996-04-29
FI960749A0 (fi) 1996-02-19
BR9407306A (pt) 1996-10-08
NZ271617A (en) 1996-11-26
FI960749A (fi) 1996-02-19
WO1995005807A1 (en) 1995-03-02
NO960653D0 (no) 1996-02-19
JPH09501682A (ja) 1997-02-18
LT96010A (ko) 1996-06-25
CZ42596A3 (en) 1996-06-12
CN1132478A (zh) 1996-10-02

Similar Documents

Publication Publication Date Title
HUT74167A (en) A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol
KR102539030B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
US20190269620A1 (en) Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
TWI508730B (zh) 含四氫葉酸之醫藥組合物
AU2004275470B2 (en) Improved stability of progestogen formulations
US20150290222A1 (en) Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
CZ12896A3 (en) Sugar coating agent and moulded tablet
EP1461043A1 (en) Oral pharmaceutical products containing 17 beta-estradiol-3 lower alkanoate, method of administering the same and process of preparation
CZ296387B6 (cs) Antikoncepcní prípravek
HU211931A9 (en) Two-stage contraception system and method using an estrogen and a progestin
JPH09502194A (ja) 少なくとも１種のプロゲストーゲンおよび少なくとも１種のエストロゲンを含む、代替療法用製剤
SK1292001A3 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy
RO115783B1 (ro) Compozitie de implant subcutanat cu efect progestativ
JP2002509524A (ja) エストロゲン化合物とプロゲステロン様化合物よりなるホルモン組成物
JPS62205024A (ja) エストロゲン欠乏症治療用組成物
JP2001523639A (ja) プロゲストゲン−抗プロゲストゲンレジメン
JP2003518013A (ja) 新規な避妊薬とその調製方法
US6670350B1 (en) Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same
Hale Phasic approach to oral contraceptives
KR102210982B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
WO2024121800A1 (en) Extended-release pharmaceutical compositions of dydrogestrone
KR20010110807A (ko) 조합 치료에서의 항프로게스타겐의 용도
CZ2001364A3 (cs) Použití biogenních estrogensulfamátů k hormonální substituční terapii
ZA200106689B (en) Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding.
WO2007009769A1 (en) Oral contraception with trimegestone

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee